Annemieke Oude Lansink-Hartgring1, Olivier van Minnen2, Karin M Vermeulen3, Walter M van den Bergh2. 1. Department of Critical Care, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 970 RB, Groningen, The Netherlands. a.oudelansink@umcg.nl. 2. Department of Critical Care, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 970 RB, Groningen, The Netherlands. 3. Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Abstract
BACKGROUND: Costs associated with extracorporeal membrane oxygenation (ECMO) are an important factor in establishing cost effectiveness. In this systematic review, we aimed to determine the total hospital costs of ECMO for adults. METHODS: The literature was retrieved from the PubMed/MEDLINE, EMBASE, and Web of Science databases from inception to 4 March 2020 using the search terms 'extracorporeal membrane oxygenation' combined with 'costs'; similar terms or phrases were then added to the search, i.e. 'Extracorporeal Life Support' or 'ECMO' or 'ECLS' combined with 'costs'. We included any type of study (e.g. randomized trial or observational cohort) evaluating hospital costs of ECMO in adults (age ≥18 years). RESULTS: A total of 1768 unique articles were retrieved during our search. We assessed 74 full-text articles for eligibility, of which 14 articles were selected for inclusion in this review; six papers were from the US, five were from Europe, and one each from Japan, Australia, and Taiwan. The sample sizes ranged from 16 to 18,684 patients. One paper exclusively used prospective cost data collection, while all other papers used retrospective data collection. Five papers reported charges instead of costs. There was large variation in hospital costs, ranging from US$22,305 to US$334,608 (2019 values), largely depending on the indication for ECMO support and location. The highest reported costs were for lung transplant recipients who were receiving ECMO support in the US, and the lowest reported costs were for extracorporeal cardiopulmonary resuscitation patients presenting with non-shockable rhythm in Japan. The additional costs of ECMO patients compared with non-ECMO patients varied between US$2518 and US$200,658. Personnel costs varied between 11 and 52% of the total amount. CONCLUSIONS: ECMO therapy is an advanced and expensive technology, although reported costs differ considerably depending on ECMO indication and whether charges or costs are measured. Combined with the ongoing gathering of outcome data, cost effectiveness per ECMO indication could be determined in the future.
BACKGROUND: Costs associated with extracorporeal membrane oxygenation (ECMO) are an important factor in establishing cost effectiveness. In this systematic review, we aimed to determine the total hospital costs of ECMO for adults. METHODS: The literature was retrieved from the PubMed/MEDLINE, EMBASE, and Web of Science databases from inception to 4 March 2020 using the search terms 'extracorporeal membrane oxygenation' combined with 'costs'; similar terms or phrases were then added to the search, i.e. 'Extracorporeal Life Support' or 'ECMO' or 'ECLS' combined with 'costs'. We included any type of study (e.g. randomized trial or observational cohort) evaluating hospital costs of ECMO in adults (age ≥18 years). RESULTS: A total of 1768 unique articles were retrieved during our search. We assessed 74 full-text articles for eligibility, of which 14 articles were selected for inclusion in this review; six papers were from the US, five were from Europe, and one each from Japan, Australia, and Taiwan. The sample sizes ranged from 16 to 18,684 patients. One paper exclusively used prospective cost data collection, while all other papers used retrospective data collection. Five papers reported charges instead of costs. There was large variation in hospital costs, ranging from US$22,305 to US$334,608 (2019 values), largely depending on the indication for ECMO support and location. The highest reported costs were for lung transplant recipients who were receiving ECMO support in the US, and the lowest reported costs were for extracorporeal cardiopulmonary resuscitation patients presenting with non-shockable rhythm in Japan. The additional costs of ECMO patients compared with non-ECMO patients varied between US$2518 and US$200,658. Personnel costs varied between 11 and 52% of the total amount. CONCLUSIONS: ECMO therapy is an advanced and expensive technology, although reported costs differ considerably depending on ECMO indication and whether charges or costs are measured. Combined with the ongoing gathering of outcome data, cost effectiveness per ECMO indication could be determined in the future.
Authors: Alain Combes; Dan Brodie; Yih-Sharng Chen; Eddy Fan; José P S Henriques; Carol Hodgson; Philipp M Lepper; Pascal Leprince; Kunihiko Maekawa; Thomas Muller; Sebastian Nuding; Dagmar M Ouweneel; Antoine Roch; Matthieu Schmidt; Hiroo Takayama; Alain Vuylsteke; Karl Werdan; Laurent Papazian Journal: Intensive Care Med Date: 2017-05-03 Impact factor: 17.440
Authors: Mark Dennis; Fredrick Zmudzki; Brian Burns; Sean Scott; David Gattas; Claire Reynolds; Hergen Buscher; Paul Forrest Journal: Resuscitation Date: 2019-03-26 Impact factor: 5.262
Authors: Murtaza I Bharmal; Joseph M Venturini; Rhys F M Chua; Willard W Sharp; David G Beiser; Corey E Tabit; Taishi Hirai; Jonathan R Rosenberg; Janet Friant; John E A Blair; Jonathan D Paul; Sandeep Nathan; Atman P Shah Journal: Resuscitation Date: 2019-02-01 Impact factor: 5.262
Authors: Alain Combes; David Hajage; Gilles Capellier; Alexandre Demoule; Sylvain Lavoué; Christophe Guervilly; Daniel Da Silva; Lara Zafrani; Patrice Tirot; Benoit Veber; Eric Maury; Bruno Levy; Yves Cohen; Christian Richard; Pierre Kalfon; Lila Bouadma; Hossein Mehdaoui; Gaëtan Beduneau; Guillaume Lebreton; Laurent Brochard; Niall D Ferguson; Eddy Fan; Arthur S Slutsky; Daniel Brodie; Alain Mercat Journal: N Engl J Med Date: 2018-05-24 Impact factor: 91.245
Authors: Daniel Brodie; Jean-Louis Vincent; Laurent J Brochard; Alain Combes; Niall D Ferguson; Carol L Hodgson; John G Laffey; Alain Mercat; Antonio Pesenti; Michael Quintel; Arthur S Slutsky; V Marco Ranieri Journal: Chest Date: 2018-01-31 Impact factor: 9.410
Authors: Giles J Peek; Miranda Mugford; Ravindranath Tiruvoipati; Andrew Wilson; Elizabeth Allen; Mariamma M Thalanany; Clare L Hibbert; Ann Truesdale; Felicity Clemens; Nicola Cooper; Richard K Firmin; Diana Elbourne Journal: Lancet Date: 2009-09-15 Impact factor: 79.321
Authors: Pauline Yeung Ng; April Ip; Shu Fang; Jeremy Chang Rang Lin; Lowell Ling; Kai Man Chan; Kit Hung Anne Leung; King Chung Kenny Chan; Dominic So; Hoi Ping Shum; Chun Wai Ngai; Wai Ming Chan; Wai Ching Sin Journal: J Thorac Dis Date: 2022-06 Impact factor: 3.005
Authors: Carlo Alberto Mazzoli; Valentina Chiarini; Carlo Coniglio; Cristian Lupi; Marco Tartaglione; Lorenzo Gamberini; Federico Semeraro; Giovanni Gordini Journal: J Clin Med Date: 2022-01-29 Impact factor: 4.241